共 47 条
[1]
Reading SR(2019)Risk factors for medication non-adherence among atrial fibrillation patients BMC Cardiovasc Disord 19 38-992
[2]
Black MH(2011)Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 981-1151
[3]
Singer DE(2009)Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 1139-236
[4]
Granger CB(2017)Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration BMC Cardiovasc Disord 17 236-2173
[5]
Alexander JH(2016)Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation J Am Heart Assoc 5 e003074-988
[6]
McMurray JJ(2015)Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure Curr Med Res Opin 31 2167-173
[7]
Connolly SJ(2017)Adherence to rivaroxaban compared with other oral anticoagulant agents among patients with nonvalvular atrial fibrillation J Manag Care Spec Pharm 23 980-1113
[8]
Ezekowitz MD(2016)Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States Int J Cardiol 212 171-1705
[9]
Yusuf S(2016)The GRACE checklist: a validated assessment tool for high quality observational studies of comparative effectiveness J Manag Care Spec Pharm 22 1107-144
[10]
Borne RT(2015)Adherence to oral anticoagulant therapy in secondary stroke prevention—impact of the novel oral anticoagulants Patient Prefer Adher 9 1695-497